Ying Di, Zhang Tianshou, Qi Manlin, Han Bing, Dong Biao
Department of Oral Geriatrics, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.
ACS Biomater Sci Eng. 2025 Apr 14;11(4):2008-2036. doi: 10.1021/acsbiomaterials.4c01940. Epub 2025 Mar 14.
Infected bone defects, caused by bacterial contamination following disease or injury, result in the partial loss or destruction of bone tissue. Traditional bone transplantation and other clinical approaches often fail to address the therapeutic complexities of these conditions effectively. In recent years, advanced biomaterials have attracted significant attention for their potential to enhance treatment outcomes. This review explores the pathogenic mechanisms underlying infected bone defects, including biofilm formation and bacterial internalization into bone cells, which allow bacteria to evade the host immune system. To control bacterial infection and facilitate bone repair, we focus on antibacterial materials for bone regeneration. A detailed introduction is given on intrinsically antibacterial materials (e.g., metal alloys, oxide materials, carbon-based materials, hydroxyapatite, chitosan, and Sericin). The antibacterial functionality of bone repair materials can be enhanced through strategies such as the incorporation of antimicrobial ions, surface modification, and the combined use of multiple materials to treat infected bone defects. Key innovations discussed include biomaterials that release therapeutic agents, functional contact biomaterials, and bioresponsive materials, which collectively enhance antibacterial efficacy. Research on the clinical translation of antimicrobial bone materials has also facilitated their practical application in infection prevention and bone healing. In conclusion, advancements in biomaterials provide promising pathways for developing more biocompatible, effective, and personalized therapies to reconstruct infected bone defects.
由疾病或损伤后细菌污染引起的感染性骨缺损会导致骨组织部分丧失或破坏。传统的骨移植和其他临床方法往往无法有效应对这些病症的治疗复杂性。近年来,先进的生物材料因其改善治疗效果的潜力而备受关注。本综述探讨了感染性骨缺损的致病机制,包括生物膜形成和细菌内化进入骨细胞,这些机制使细菌能够逃避宿主免疫系统。为了控制细菌感染并促进骨修复,我们重点关注用于骨再生的抗菌材料。详细介绍了固有抗菌材料(如金属合金、氧化物材料、碳基材料、羟基磷灰石、壳聚糖和丝胶蛋白)。骨修复材料的抗菌功能可通过掺入抗菌离子、表面改性以及多种材料联合使用等策略来增强,以治疗感染性骨缺损。讨论的关键创新包括释放治疗剂的生物材料、功能性接触生物材料和生物响应性材料,这些材料共同提高了抗菌效果。抗菌骨材料的临床转化研究也促进了它们在预防感染和骨愈合方面的实际应用。总之,生物材料的进展为开发更具生物相容性、有效性和个性化的疗法来重建感染性骨缺损提供了有前景的途径。
ACS Biomater Sci Eng. 2025-4-14
Int J Mol Sci. 2021-4-23
ACS Biomater Sci Eng. 2025-3-10
J Mech Behav Biomed Mater. 2024-9
J Nanobiotechnology. 2025-3-29
Front Biosci (Schol Ed). 2013-1-1
J Mater Chem B. 2021-3-21